Wittwer, Kevin
Anderson, Danielle E.
Pfeffermann, Kristin
Cox, Robert M. http://orcid.org/0000-0003-0620-1674
Wolf, Josef D.
Santibanez, Sabine
Mankertz, Annette
Plesker, Roland
Sticher, Zachary M. http://orcid.org/0000-0002-7022-1410
Kolkykhalov, Alexander A.
Natchus, Michael G.
Pfaller, Christian K. http://orcid.org/0000-0003-3302-0780
Plemper, Richard K. http://orcid.org/0000-0003-2034-2107
von Messling, Veronika
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI071002)
Deutsche Forschungsgemeinschaft (CRC1021/B09)
Article History
Received: 19 February 2021
Accepted: 12 August 2021
First Online: 2 September 2021
Competing interests
: R.K.P. is a co-inventor on US patent US9499489B2, “Myxovirus therapeutics, compounds, and uses related thereto”, which covers composition of matter and the method of use of ERDRP-0519 for measles therapy. This study could affect his personal financial status. All other authors declare no competing interests.